Delivery Order SPE2DB25D3404-SPE2DB25FUPRW
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,655.27 and an ultimate completion date of October 28, 2025. The contract involves no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award, valued at $15,789.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,092,751 units of the medication Deferasirox 500 mg tablets for suspension, with a performance period ending on May 1, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. Amerisourcebergen Drug Corp, the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,063.08, is for the delivery of Deferiprone 1,000 mg tablets to support military healthcare programs. The contract is a firm-fixed price type, with an ultimate completion date of January 18, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DEFERIPRONE 500 MG TABLET 100S. The contract has a ceiling value of $36,056.43 and a completion date of June 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, for the supply of Jadenu 360 mg tablets (30-count) valued at $36,535.05. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded with no set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The place of performance is AmerisourceBergen's...